anthracyclines
These results show that expression of the alphaCM/h-mdr1       transgene in heart confers protection from the toxic effect of Adriamycin and       suggest that such constructs, if employed effectively in cardiac gene therapy       protocols, could allow a more aggressive use of anthracyclines in the treatment       of cancer.
These results show that expression of the alphaCM/h-mdr1       transgene in heart confers protection from the toxic effect of Adriamycin and       suggest that such constructs, if employed effectively in cardiac gene therapy       protocols, could allow a more aggressive use of  @SUBJECT$  in the  @PREDICAT$        of  @OBJECT$ .